- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Baggett, J. J.
- Articles by Wendland, B.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Baggett, J. J.
- Articles by Wendland, B.
The Sla2p Talin Domain Plays a Role in Endocytosis in Saccharomyces cerevisiae
Jennifer J. Baggetta, Katharine E. D'Aquino1,a, and Beverly Wendlandaa Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218
Corresponding author: Beverly Wendland, Mudd Hall, Room 35, 3400 N. Charles St., The Johns Hopkins University, Baltimore, MD 21218., bwendland{at}jhu.edu (E-mail)
Communicating editor: T. STEARNS
| ABSTRACT |
|---|
Clathrin-binding adaptors play critical roles for endocytosis in multicellular organisms, but their roles in budding yeast have remained unclear. To address this question, we created a quadruple mutant yeast strain lacking the genes encoding the candidate clathrin adaptors Yap1801p, Yap1802p, and Ent2p and containing a truncated version of Ent1p, Ent1
CBMp, missing its clathrin-binding motif. This strain was viable and competent for endocytosis, suggesting the existence of other redundant adaptor-like factors. To identify these factors, we mutagenized the quadruple clathrin adaptor mutant strain and selected cells that were viable in the presence of full-length Ent1p, but inviable with only Ent1
CBMp; these strains were named Rcb (requires clathrin binding). One mutant strain, rcb432, contained a mutation in SLA2 that resulted in lower levels of a truncated protein lacking the F-actin binding talin homology domain. Analyses of this sla2 mutant showed that the talin homology domain is required for endocytosis at elevated temperature, that SLA2 exhibits genetic interactions with both ENT1 and ENT2, and that the clathrin adaptors and Sla2p together regulate the actin cytoskeleton and revealed conditions under which Yap1801p and Yap1802p contribute to viability. Together, our data support the view that Sla2p is an adaptor that links actin to clathrin and endocytosis.
PLASMA membrane lipids and proteins, as well as contents of the extracellular space, are internalized by the formation of vesicles budding into the cytoplasm from the plasma membrane. This process, known as endocytosis, is vital to all cells for growth, signaling, and nutrient uptake. Although several endocytic pathways exist, the clathrin-dependent pathway is the best characterized. Clathrin is a heterohexameric coat protein that is believed to drive curvature of the membrane to form a vesicle during both endocytic and secretory pathway events (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Adaptor proteins, which select the protein cargo to be included in internalizing vesicles and also recruit endocytic machinery, have been the subject of many recent studies (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
![]()
One conserved family of endocytosis proteins is the epsins, which are thought to be adaptors. They contain a conserved structural domain at their N terminus called ENTH (epsin N-terminal homology), which binds phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2; ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Two other potential endocytic proteins, Yap1801p and Yap1802p, are highly homologous to the mammalian clathrin assembly factors CALM/AP180 (![]()
![]()
![]()
![]()
![]()
An important actin and endocytic protein, Sla2p, also contains an N-terminal structural domain similar to the ENTH domain. Unlike the four proteins described above, however, Sla2p was originally isolated as an actin-regulatory protein in a synthetic lethal with abp1
screen (![]()
![]()
![]()
![]()
![]()
![]()
strains are viable, but are temperature sensitive for growth and have both endocytosis and actin cytoskeletal defects (![]()
![]()
| MATERIALS AND METHODS |
|---|
Media and materials:
Rich medium for yeast strain growth is standard yeast extract-peptone-dextrose (YPD). Synthetic medium contains yeast nitrogenous base plus dextrose and is supplemented with appropriate amino acids to maintain plasmid selection. 5-Fluoroorotic acid (5-FOA) was used at 750 µg/ml in synthetic medium. Bacterial strains were maintained on standard media containing 50 µg/ml carbenicillin (US Biologicals, Swampscott, MA), 30 µg/ml kanamycin, or 34 µg/ml chloramphenicol as appropriate to maintain plasmids. Materials were purchased from Fisher Scientific (Pittsburgh) or Sigma (St. Louis) unless otherwise noted.
Yeast strains and plasmids:
Table 1 and Table 2 list yeast strains and plasmids used in this study, respectively. DNA deletions and manipulations were performed using standard techniques. JRY41 was derived by sporulation and tetrad dissection of the diploid DDY1194 (![]()
CBM at the ENT1 locus in ent1::HIS3 ent2::HIS3 + pENT2 cells was achieved using an integrating LEU2 vector, linearized by restriction digest downstream of the ent1
CBM stop codon. To create the ent1
CBM triple-
strain, cells that had integrated ent1
CBM were selected and confirmed by PCR and Western analysis and then crossed to ent2::HIS3 yap1801::HIS3 yap1802::LEU2 cells. The quadruple mutant ent1::HIS3::ent1
CBM::LEU2 ent2::HIS3 yap1801::HIS3 yap1802::LEU2 was selected by tetrad analysis and Western blotting. BWY1413 was generated by four sequential backcrosses of SEY6210 to end4-1 (![]()
![]()
|
|
Growth of yeast cells in serial dilution:
Yeast cells were grown in liquid culture to mid-log phase. Cells were then serially diluted to 0.25, 0.05, 0.01, and 0.002 OD600/ml. The diluted cells were transferred to solid media using a pronged "frogger" or replicator tool and grown for 15 days at the temperatures shown.
Isolation of Rcb mutants and treatment of rcb432 and rcb243:
The strains JRY18 (MATa) and JRY19 (MAT
) were mutated with ethyl methanesulfonate (EMS) to
30% viability. We screened a total of
25,000 colonies, and Rcb (requires clathrin binding) mutants were identified as dead colonies on 5-FOA media by replica plating. All colonies selected were retested by streaking as well as by plating serially diluted cells. rcb432 was backcrossed at least twice to JRY18 or JRY19 using standard techniques to determine linkage of a single mutation to the phenotypes. Outcrossing to SEY6210 was also performed to obtain the rcb432 mutation, sla2-432, alone and in the background of ent1
or ent2
. Complementation cloning was performed using a CEN, TRP1 genomic library from C. CONNELLY and P. HIETER (unpublished data). To confirm linkage between sla2-432 and SLA2, we tagged the SLA2 locus with TRP1 in ent2::HIS3 cells and mated them to sla2-432 ent2::HIS3 cells (JRY31). Tetrad analysis of this mating showed 100% segregation of SLA2::TRP1 away from sla2-432 (identified by temperature-sensitive growth in the ent2
background). To sequence the sla2-432 allele, genomic DNA was isolated and PCR was used to amplify the SLA2 gene. Sequencing was performed in triplicate using overlapping primers and compared to wild-type SLA2 sequence obtained by the same methods.
rcb243 cells were found to be in the same complementation group as rcb432 by mating the two mutant strains and testing for inviability on 5-FOA media. However, Western blot analysis showed that rcb243 cells produce full-length Sla2p, and transformation with pSLA2 only partially complemented the Rcb phenotype of rcb243 cells. This could be due to a dominant effect of the sla2 allele found in rcb243 cells or to a mutation in a gene other than SLA2 that results in nonallelic noncomplementation.
Trichloro-acetic acid precipitated yeast cell extracts:
Yeast cells were grown to mid-log phase and equal numbers of cells were harvested by centrifugation. Cells were resuspended in 10% trichloro-acetic acid containing the protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF, 0.1 mM) and incubated for 20 min at 4°. Extracted proteins were pelleted by centrifugation and washed twice in acetone. Dried pellets were resuspended in Laemmli buffer with 0.1 mM AEBSF and subjected to standard glass bead disruption. Proteins were separated by SDS-PAGE and subjected to immunoblotting.
SDS-PAGE and immunoblotting:
Proteins were separated on 7.515% polyacrylamide minigels at 2030 mA in running buffer (3 mM SDS, 25 mM Tris base, 192 mM glycine). Proteins were then transferred onto nitrocellulose membrane in Western transfer buffer (20% methanol, 0.0375% SDS, 48 mM Tris base, 39 mM glycine) for 90 min at 80 V, followed by blocking in 5% nonfat dried milk in TBST (0.25 M NaCl, 10 mM Tris, pH 7.5, 0.025% Tween-20). Blots were incubated with the given primary antibodies, washed in TBST, incubated with secondary antibodies conjugated to HRP obtained from Pierce (Rockford, IL) and used at 1:5000 for 3045 min, and developed with SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL) for 5 min. Proteins were visualized on a Fluorchem 8000 chemiluminescence system (Alpha Innotech, San Leandro, CA). Quantification of band intensity was performed using the Fluorchem 2.0 software analysis system. Monoclonal anti-clathrin heavy chain antibody (skl1) was provided by S. Lemmon (Case Western Reserve University). Polyclonal anti-clathrin light chain serum and anti-Ste3p serum were the generous gift of G. Payne (UCLA), and polyclonal serum against the N terminus of Sla2p was provided by D. Drubin (![]()
Clathrin-binding assay:
His6-IC2-N237 (negative control), Ent1p, Ent1
CBMp, Ent2p, and Ent2
CBMp (pRSET-IC2-N237, pBW247,241,493,494) were transformed into Rosetta(DE3) cells (Novagen, Madison, WI). Bacteria were grown at 37° overnight in Luria-Bertani medium plus 30 µg/ml kanamycin, 34 µg/ml chloramphenicol, and 10 mg/ml dextrose. These cells were diluted
1:15 from saturation into superbroth plus kanamycin and chloramphenicol and grown for 3 hr at 37°. Cells were cooled and induced with 1 mM isopropyl thiogalactoside (RPI, Mt. Prospect, IL) for 5 hr at 30°. Cells were washed in 50 mM glucose plus 10 mM EDTA, and cell pellets were frozen at -20° to initiate lysing. To prepare lysates, cell pellets were thawed and resuspended in lysis buffer (20 mM Tris, pH 7.5, 1 mM EDTA, 0.4 mg/ml lysozyme, 0.2 mM AEBSF) and incubated at room temperature for 20 min. Lysates were sonicated and cell debris was removed by centrifugation. KCl and Tween-20 were added to a concentration of 150 mM and 0.2%, respectively, to the final lysate.
Lysates were incubated with nickel agarose beads (QIAGEN, Valencia, CA) for 12 hr at 4° to allow binding. Protein-bound beads were washed several times with phosphate-buffered saline and then tested for approximately equal concentrations of protein bound by SDS-PAGE and standard Coomassie staining. To test His6-tagged proteins for binding to yeast proteins, protein-bound beads were incubated with yeast cytosol (prepared by glass bead lysis and high-speed centrifugation as described in ![]()
Ste3p stabilization assay:
Yeast cells were grown in liquid culture to mid-log phase and then diluted to equal concentrations. Cells were preshifted to assay temperature for 515 min before treatment with cycloheximide to a final concentration of 5 µg/ml at time zero. Equal volumes of cells were removed at chase timepoints of 0, 10, 20, 40, 60, and 90 min into azide/fluoride stop solution (final concentration 10 mM NaF, 10 mM NaN3) and maintained on ice. Cell extracts were prepared by resuspension of cell pellets in Laemmli urea sample buffer and standard glass bead disruption methods. Care was taken not to heat samples above 70° to prevent aggregation of Ste3p. Extracts were run on 10% acrylamide SDS-PAGE gels and immunoblotted with polyclonal anti-Ste3p serum (pretreated with Ste3p delete extract to reduce background).
Green fluorescent protein fusion proteins:
pSTE3-green fluorescent protein (GFP) was the gift of R. Piper (![]()
Staining of filamentous actin with rhodamine-phalloidin:
Cells were grown to early to mid-log phase at 26°. Cells were then either subjected to 90 min preshift to 37° or fixed immediately. Fixation was achieved in media supplemented with 4% formaldehyde and 0.1 M potassium phosphate, pH 6.5, for 12 hr. Cells were sometimes additionally fixed overnight in 4% formaldehyde in 0.1 M potassium phosphate, pH 6.5. After several washes in phosphate-buffered saline (PBS), cells were permeabilized in 0.02% Triton X-100 for 15 min. Cells were washed in PBS and labeled with 3050 µl of 0.6 µM rhodamine-phalloidin (Molecular Probes, Eugene, OR) for 1 hr to overnight. Cells were washed and resuspended in DABCO (triethylene diamine) antifade and were viewed under TRITC filters on a Deltavision deconvolving fluorescence microscope. Images were deconvolved using Deltavision software to eliminate out-of-focus light.
| RESULTS |
|---|
Characterization of a C-terminal clathrin box motif:
The mammalian LLDLD clathrin box motif binds to the terminal domain of clathrin heavy chain (![]()
![]()
D
Stop (
, bulky hydrophobic residue, Fig 1A), with the stop codon immediately following the four-amino-acid motif as a key element that mimics the last aspartic acid of the clathrin box motif. The Ent1p and Yap1801p CBMs were shown previously to be sufficient for binding to clathrin (![]()
CBMp and Ent2
CBMp. We constructed plasmids encoding His6-tagged versions of Ent1p, Ent1
CBMp, Ent2p, and Ent2
CBMp, and overexpressed the proteins in Escherichia coli. Lysates containing proteins of the expected size were incubated with nickel agarose beads. Wild-type yeast extracts were then incubated with the immobilized His6-protein beads and washed, and then bound and unbound fractions were separated by SDS-PAGE and analyzed by immunoblotting with antibodies against clathrin heavy and light chains (Fig 1B). The bound fraction was also probed with antibodies to the His6-tag, which confirmed that approximately equal amounts of protein were present in each lane (not shown). The results showed that the clathrin heavy chain (Chc1p) bound both wild-type Ent1p and wild-type Ent2p (Fig 1B, lanes 2 and 4), while neither Ent1
CBMp nor Ent2
CBMp showed any binding (Fig 1B, lanes 3 and 5). Even though their C termini are identical, Ent2p appeared to bind more clathrin than did Ent1p. Both Ent1
CBMp and Ent2
CBMp showed some residual clathrin light chain (Clc1p) in the bound fraction, but quantification showed this to be <1% of wild-type levels for Ent1p, while we consistently observed
3% of wild-type levels for Ent2p. These data indicate that the C-terminal CBMs of Ent1p and Ent2p are both necessary and sufficient for clathrin heavy chain binding.
|
Phenotypes of ENT1, ENT2, YAP1801, and YAP1802 mutants:
Saccharomyces Genome Database (http://genome-www.stanford.edu/Saccharomyces) pattern match searches with the sequence [LI][LI][DE][LIM]-COOH identified the C-terminal CBM in Ent1p, Ent2p, Yap1801p, and Yap1802p, as well as untested CBMs in the vacuolar sorting protein Vps27p, which is involved in sorting at the late endosome, and the uncharacterized products of YML036w and YEL015w. It has been previously shown that the strain yap1801
yap1802
has no recognizable phenotypes (![]()
ent2
is inviable (![]()
ent2
cell inviability is due solely to lack of the N-terminal ENTH domain (![]()
![]()
![]()
![]()
![]()
CBM at the ENT1 locus, and ENT2, YAP1801, and YAP1802 were deleted (genotype abbreviated as ent1
CBM triple-
). We used ent1
CBM rather than a larger deletion of ENT1 to avoid complications from loss of other functional regions of the yeast epsins. Ent1
CBMp was produced at equivalent levels to the wild-type protein (not shown).
The quadruple mutant strain ent1
CBM triple-
was created in the presence of pENT1, a plasmid containing wild-type ENT1 and URA3 as its selectable marker. The requirement for these four CBMs for growth and viability was tested using the mutant strain ent1
CBM triple-
[pENT1] and plating on YPD and 5-FOA at 26° and 37° (Fig 1C). On 5-FOA, which forces cells to grow in the absence of pENT1, ent1
CBM triple-
cells grew similarly to wild-type cells transformed with empty vector. This suggests that the combined loss of the CBMs of these four endocytic proteins is not detrimental to growth.
Following the determination that ent1
CBM triple-
cells do not have growth defects at permissive or restrictive temperature, we investigated endocytosis in these cells. Wild-type, ent1
CBM triple-
[pENT1], and ent1
CBM triple-
cells were tested at 26° and 37° for uptake of the lipophilic dye FM4-64 to assess internalization rates and internal trafficking of bulk lipids (![]()
In addition to bulk endocytosis rates, we analyzed trafficking of the Ste3p receptor transmembrane protein. In MAT
cells, Ste3p is constitutively endocytosed in the absence of mating pheromone and delivered to the vacuole for degradation with a t1/2
1520 min (![]()
CBM triple-
[pENT1], and ent1
CBM triple-
cells were tested to evaluate rates of Ste3p degradation and results from at least three independent experiments were averaged (Fig 1D). Neither ent1
CBM triple-
[pENT1] nor ent1
CBM triple-
cells exhibited a kinetic defect in uptake and degradation of Ste3p by this assay. We also examined live cells for localization of two GFP fusion proteins, Ste3-GFP (![]()
![]()
Rcb screen for additional endocytic factors:
Because the ent1
CBM triple-
cells had no detectable phenotype, we reasoned that additional endocytic factors may be functioning redundantly with these adaptor proteins in selecting receptors for endocytosis and recruitment of the required machinery. On the basis of this idea, we designed a screen to identify novel proteins that may be fulfilling this redundant function. We mutagenized ent1
CBM triple-
[pENT1] cells with EMS and allowed cells to recover on minimal media. Colonies that required wild-type ENT1 (encoded by the pENT1 plasmid) for viability were identified by replica plating mutagenized cells to 5-FOA at 26°. Twenty-six colonies that were consistently inviable on 5-FOA were designated rcb mutants, for their inability to grow in the absence of the four known adaptor protein CBMs. Of these,
65% were 5-FOA sensitive, even if wild-type ENT1 was supplied by an additional plasmid (that can be maintained on 5-FOA), and were discarded. The remaining nine mutants were mated to ent1
CBM triple-
[pENT1] cells and confirmed to contain recessive mutations. These mutants were then mated to one another and tested for complementation. Seven of the nine mutants were placed into one complementation group; however, transformation with plasmids containing ent1
CBM allowed rescue, indicating that all seven mutants were likely to contain mutations in genomic ent1
CBM that caused the Rcb phenotype. These seven were set aside. The remaining two Rcb mutant strains, rcb243 and rcb432, comprised a second complementation group and were selected for further study.
Characterization of rcb432, a temperature-sensitive Rcb mutant:
For the following studies, rcb243 and rcb432 were characterized in the background of ent1
CBM triple-
[pENT1], and their viability requirement for the Ent1p CBM prevented examination of any phenotypes in a completely
CBM environment. For simplicity, the nonitalicized strain names rcb243 and rcb432 will be used to refer to cells with the rcb and ent1
CBM triple-
[pENT1] mutations. The two Rcb mutant strains were tested for temperature sensitivity at 37° and cold sensitivity at 14° by plating equal volumes of liquid cultures to rich medium (YPD) and incubating at several temperatures. Both the rcb243 and the rcb432 strains were inviable at 37°. rcb432 was selected for more detailed analysis, as rcb243 cells proved more difficult to work with (see MATERIALS AND METHODS). Transformation of rcb432 with single-copy plasmids containing ENT2, YAP1801, or YAP1802 or an additional copy of ENT1 confirmed that one of any of the four CBM-containing proteins was capable of rescuing viability on 5-FOA (Fig 2A, rows 3, 5, 7, and 8). Interestingly, only Ent2p rescued the temperature-sensitive growth at 37° (Fig 2A, row 5). Introducing a plasmid encoding an additional copy of Ent1
CBMp did not restore growth on 5-FOA (Fig 2A, row 4), indicating that the rcb432 strain was not isolated due to a mutation in ent1
CBM at the ENT1 locus. While together these data confirmed the Rcb phenotype, where any of the four CBM-containing proteins restored viability, supplementing rcb432 cells with a plasmid containing ent2
CBM also partially rescued both inviability on 5-FOA at 26° and temperature-sensitive growth at 37° (Fig 2A, row 6). Thus, rcb432 is inviable in the absence of all of the four CBMs, unless both Ent1
CBMp (genomic) and Ent2
CBMp (episomal) are present.
|
Because the yeast epsins and AP180s are implicated in endocytosis, we tested rcb432 cells for endocytic defects. Bulk lipid uptake by the FM4-64 assay described above at 26° and 37° was not significantly different in rcb432, wild-type, or parental strains (not shown). Ste3p degradation was also measured as described above after cycloheximide treatment at 26° and 37°. Ste3p degradation in rcb432 cells was not significantly different from wild-type or parental strains at 26° (not shown), whereas no degradation occurred at all over the 90-min chase time in rcb432 cells at 37° (Fig 2C). To determine where trafficking of Ste3p is blocked, we observed localization of the fusion protein Ste3-GFP (![]()
Complementation cloning of rcb432 shows that it is an allele of SLA2:
We confirmed that a single recessive chromosomal mutation is responsible for the Rcb phenotype and temperature-sensitive growth by mating rcb432 to its parent strain ent1
CBM triple-
[pENT1] and observing 2:2 cosegregation of both phenotypes. Complementation cloning with a single-copy genomic library (TRP1) was then performed to identify the additional gene mutated in rcb432 cells. Cells were transformed and tested for rescue of inviability at the restrictive temperature, 37°. The temperature-resistant colonies were then tested for viability on 5-FOA. From these cells, we isolated two independent library fragments capable of rescuing both phenotypes that each contained SLA2; one also contained APG2. Because SLA2 is known to be involved in both endocytosis and actin cytoskeleton regulation, we subcloned SLA2 into a new vector (pSLA2) and found that SLA2 alone rescued both temperature-sensitive growth and death on 5-FOA (Fig 2B). In addition, transformation of rcb432 cells with pSLA2 also rescued the endocytic defect as measured by Ste3p degradation at 37° (Fig 2C).
To confirm that rcb432 cells indeed harbored a mutation in SLA2 and to identify the specific mutation, we performed linkage analysis followed by sequencing of the entire SLA2 gene in both wild-type and rcb432 strains (see MATERIALS AND METHODS). The sla2 allele from rcb432 differed from wild-type SLA2 in only one nucleotide (C2374T). This results in a nonsense mutation from glutamine to a stop codon, Q792stop, within the talin homology domain (Fig 3A). This rcb mutation, sla2792stop, was named sla2-432. For comparison, we also sequenced the end4-1/sla2-41 allele that was isolated and described by ![]()
|
Endocytosis is defective in sla2-432 cells:
We mated the original rcb432 strain (sla2-432 ent1
CBM triple-
[pENT1]) to wild type to obtain cells containing only the sla2-432 allele for further characterization. We also crossed sla2-432 into ent1
and ent2
backgrounds. Growth at permissive (26°) and restrictive (37°) temperatures showed that sla2-432 alone is viable at 37°, but when combined with either ent1
or ent2
, the cells became temperature sensitive for growth (Fig 3B). To determine the functional domains of Ent1p and Ent2p that are required for viability at 37°, we transformed sla2-432 ent1
and sla2-432 ent2
cells with several mutated or truncated ENT1 or ENT2 constructs and evaluated growth at restrictive temperature. As summarized in Table 3, we found that rescue of temperature sensitivity of either sla2-432 ent1
or sla2-432 ent2
required the addition of the majority of the corresponding Ent1p or Ent2p, including the ENTH domain and the UIMs. In contrast, the CBM was dispensable. This indicated that the sla2-432 allele exhibited genetic interactions with either ENT1 or ENT2, resulting in temperature sensitivity when the majority or all of either gene is absent.
|
We next tested endocytosis in both sla2-432 and sla2-432 ent2
cells by monitoring Ste3p degradation. As shown in Fig 3C, the temperature-sensitive endocytosis defect was present in sla2-432 cells despite a lack of temperature-sensitive growth. In addition, sla2-432 cells expressing STE3-GFP constructs showed plasma membrane accumulation of Ste3p (not shown) that was similar to rcb432 cells in Fig 2D, indicating the endocytosis block was still at the internalization step. This indicated that the two temperature-sensitive phenotypes were independent of each other and, particularly, that the endocytic defect was independent of the presence or absence of Ent2p. This endocytosis defect was, however, rescued by the addition of wild-type Sla2p (not shown). This indicates that, while both the growth and endocytosis phenotypes are linked to the sla2-432 allele, temperature-sensitive growth is due to a genetic interaction with either ENT1 or ENT2, while the endocytic defect at 37° is due solely to the sla2-432 mutation itself.
Low Sla2 protein levels result in the temperature-sensitive growth of sla2-41 and sla2-432 alleles:
Sequencing the sla2-432 and sla2-41 alleles revealed nonsense mutations that should encode truncated proteins. To confirm the presence of the expected truncated proteins in sla2-432 and sla2-41 cells, whole-cell yeast extracts of equal numbers of cells were prepared from wild type, sla2-432, sla2-41, and a previously characterized SLA2 truncation mutant, sla2
768-968, that encodes a protein only 24 amino acids shorter than Sla2-432p (Fig 3A; ![]()
![]()
![]()
768-968 cells produced a protein of a size similar to that in sla2-432, but Sla2
768-968p levels were more similar to those in wild type.
|
The truncated sla2
768-968 allele was engineered to delete the entire talin homology domain and was previously shown to rescue the temperature-sensitive growth, endocytosis, and actin defects of sla2
cells (![]()
768-968p, missing the talin domain, replaced wild-type Sla2p, uptake of the fluid-phase dye Lucifer yellow was normal at both low (25°) and elevated (37°) temperatures (![]()
768-968 ent2
strain and tested it for growth and endocytosis. Unlike the temperature-sensitive sla2-432 ent2
strain, we found that growth of sla2
768-968 ent2
was similar to that of wild type at 37° (not shown). However, Ste3p degradation assays showed that both sla2
768-968 and sla2
768-968 ent2
cells exhibited a significant endocytic defect at 37° (Fig 4B). While this result is in contrast to the normal endocytic rates previously reported with talin domain deletion proteins (using Lucifer yellow assays), sla2-432 also exhibited normal bulk endocytic flow at low and high temperatures (as measured by FM4-64 uptake). We interpret these data to suggest that general internalization rates are not affected in either sla2-432 or sla2
768-968, but that the endocytosis of specific receptor proteins is selectively affected at high temperatures.
sla2
cells are temperature sensitive in an otherwise wild-type background, while sla2-432 (but not sla2
768-968) cells are temperature sensitive for growth only in an ent1
or ent2
background. Therefore, we hypothesized that the decreased protein levels of Sla2-432p in combination with ent1
or ent2
might be the cause of the temperature-sensitive growth phenotype. To differentiate between the contributions of low protein levels vs. the loss of the talin homology domain to the temperature-sensitive growth and endocytic defects in sla2-432 cells, we increased the amount of Sla2-432p and tested for growth and endocytosis. Higher protein levels were achieved by introducing a single-copy plasmid encoding the sla2-432 allele into sla2-432 ent2
cells, which partially reversed inviability at 37° (Fig 4C). Quantitative immunoblotting with anti-Sla2p antibodies showed that sla2-432 ent2
cells expressed the truncated protein at
40% of wild-type protein levels, while sla2-432 ent2
[psla2-432] cells expressed the truncated protein at 60% of wild-type protein levels (not shown). Thus, an additional 50% of the truncated protein is able to rescue temperature-sensitive growth, indicating that the reduced level of Sla2-432p is likely to be the major cause of the temperature-sensitive growth phenotype when ENT2 is deleted. In contrast, endocytosis as measured by Ste3p degradation did not benefit from higher levels of Sla2-432p (Fig 3C). This indicates a segregation of two major phenotypes of the sla2-432 mutation. The temperature-sensitive endocytosis defect appears to be due mainly to loss of the talin domain, while temperature-sensitive growth in the absence of Ent1p or Ent2p appears to be mainly a function of decreased SLA2 protein levels.
sla2-432 cells exhibit actin defects that are exacerbated by loss of the 4 CBM-containing proteins:
A dynamic actin cytoskeleton is required for endocytosis in yeast cells, and numerous links between organization and regulation of the actin cytoskeleton have been shown for both yeast and mammals (reviewed in ![]()
![]()
![]()
|
Sla2p is believed to play a key role in regulation of cortical actin patches and localizes to multiple cortical patches at the plasma membrane of growing buds with
8090% colocalization to actin patches in small-budded cells (![]()
![]()
![]()
CBM triple-
[pENT1]) as well as sla2-432 ent2
and sla2-432 cells with rhodamine-conjugated phalloidin, which labels filamentous actin. Cells were grown at 26° and either fixed immediately at 26° or shifted to 37° for 90 min, followed by fixation (Fig 5). At both permissive (26°) and nonpermissive (37°) temperatures, the original rcb432 cells had distinct, large, cortically located F-actin clumps in
60% of cells (Fig 5C). Polarization was also affected in these mutants, with the large, cortical clumps distributed in both mother cells and small buds. Similar to the rescue of endocytosis defects and temperature sensitivity, addition of wild-type Sla2p to rcb432 cells rescued most of the actin cytoskeletal defects (Fig 5F). In sla2-432 ent2
and sla2-432 cells, the actin defect was much less pronounced and was characterized by only
1050% of the cells with smaller chunky or depolarized, but still cortical, F-actin patches (Fig 5D and Fig E). Thus, the CBM-containing proteins also contribute to actin organization since their presence partially suppresses the severe actin defects seen in rcb432 cells.
To determine whether the formation of these abnormally large cortical patches was due to decreased Sla2-432p levels or loss of the talin domain, we stained rcb432 cells alone, plus pSLA2, or plus psla2-432 at 26°. Using blind quantification, both rcb432 cells and rcb432 [psla2-432] cells contained an abnormal, large F-actin patch in
60% of cells, and 3040% of the cells were depolarized. In contrast, rcb432 [pSLA2] cells contained only 30% of cells with an abnormal large patch and exhibited >80% polarization (Fig 5F). The lack of complete rescue in rcb432 [pSLA2] cells indicates that Sla2-432p has a partially dominant effect on actin organization. In addition, rescue of the rcb432 endocytosis defect by pSLA2 is also not complete (Fig 2C). The idea that Sla2-432p may have dominant effects is not surprising given reports that Sla2p is likely to homodimerize (![]()
![]()
| DISCUSSION |
|---|
The subject of clathrin-dependent internalization in yeast cells remains controversial in spite of clathrin deletion and temperature-sensitive mutants revealing a significant role for clathrin in endocytosis (reviewed in ![]()
CBM triple-
, missing all four endocytic CBMs, failed to display any overt endocytic or growth phenotypes (Fig 1), we postulated the existence of other, redundant clathrin-binding proteins acting as adaptors in yeast. We designed the Rcb screen to isolate these factors, as well as clathrin-independent endocytic factors acting in parallel to the clathrin-dependent pathway. From this screen, we isolated rcb432, containing a mutation in the gene SLA2.
rcb432 cells (sla2-432 ent1
CBM triple-
[pENT1]) exhibited normal bulk lipid endocytosis (by FM4-64 uptake), but at 37° were defective for endocytosis of Ste3p, a constitutively internalized transmembrane receptor. Signals that trigger endocytosis on the cytosolic tail of Ste3p have been well characterized (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
CBMp and Ent2
CBMp, as well as the discovery that Ste3p endocytosis is blocked in sla2-432 cells, even in the presence of all four CBM-containing adaptor proteins (Fig 3C), indicates that Sla2p may also be playing a different or additional role to Ent1p, Ent2p, Yap1801p, or Yap1802p in the endocytosis of receptor proteins.
The talin homology domain plays an important role in endocytosis:
The sla2-432 allele has a nonsense mutation at the beginning of the talin homology domain or I/LWEQ module. On the basis of the structure of the I/LWEQ module, it is unlikely that the small N-terminal portion of the talin homology domain present in our sla2-432 allele can bind F-actin (![]()
![]()
768-968 cells (missing the entire talin homology domain) grew at elevated temperatures, but exhibited defects in receptor endocytosis, indicating that the talin domain is required for receptor endocytosis at high temperature. Previous studies of SLA2 mutants lacking only the talin homology domain did not uncover endocytic defects; however, these experiments monitored either bulk fluid phase uptake (at 25° and 37°; ![]()
-factor by the Ste2p receptor (at 24°; ![]()
![]()
-factor at low and high temperatures and found endocytosis defects only at restrictive temperatures for most alleles. Even the strong sla2-41 allele exhibits only mild endocytosis defects at permissive temperature (![]()
cells at both low and high temperatures, it is clear that Sla2p plays a key role in endocytosis. At elevated temperatures, where the heat-shock response results in reorganization of the actin cytoskeleton and rapid changes in the membrane's protein and lipid profile, the molecular function of Sla2p may be particularly important for viability. Under these conditions, even partial loss of Sla2p function may result in a strong endocytosis defect, particularly if trafficking of an Sla2p-dependent membrane protein is monitored.
That endocytosis defects are present only at high temperature in sla2 strains missing the talin homology domain indicates a requirement for this domain in Sla2p function at restrictive temperatures or perhaps in the cell's response to the temperature shift. One possibility is that the talin homology domain helps to stabilize Sla2p at cortical actin patches during the heat-shock response where it helps to reorganize the actin cytoskeleton. Alternatively, the talin domain may be involved in regulating Sla2p function. Two small coiled-coil regions surrounding the Sla2p talin homology domain occlude F-actin binding by associating with one another (![]()
sla2-432 exhibits a genetic interaction with both ENT1 and ENT2:
Unlike the endocytic phenotype that is observed regardless of genetic background, we found that sla2-432 cells were inviable at 37° only if either ENT1 or ENT2 was deleted (Fig 3B). Further testing revealed that the sla2-432 allele encoded a truncated protein that was present at lower levels than wild-type Sla2p (Fig 4A). Since sla2
768-968 ent2
cells were not temperature sensitive for growth, we asked if sla2-432 ent2
cells were inviable at 37° due to the combined loss of Ent2p and decreased Sla2 protein levels, rather than to the absence of the Sla2p talin homology domain. Increasing Sla2-432p levels by
50% in sla2-432 ent2
cells rescued inviability at 37° (Fig 4C), indicating that Sla2-432p can function in the role fulfilled by wild-type Sla2p in viability at restrictive temperature. Thus, decreased Sla2 protein levels, combined with loss of either ENT1 or ENT2, lead to a synthetic growth phenotype. By introducing ENT1 and ENT2 mutant plasmids into sla2-432 ent1
or sla2-432 ent2
cells, we identified the ENTH domains and UIMs of the yeast epsins as participants in the genetic interaction with sla2-432 (Table 3). However, if normal Sla2p levels are present, just a single ENTH domain from either Ent1p or Ent2p is sufficient for viability at 37° (our unpublished results). Taken to a greater extreme, loss of all of Sla2p results in death at 37° even when all of both Ent1p and Ent2p are present, as seen in the temperature-sensitive sla2
and sla2-41 cells. These data indicate that the temperature sensitivity in sla2
cells is also likely to be due to loss of the same essential pathway that requires the presence of either an ENT1 or ENT2 ENTH domain.
A novel role for the yeast AP180s:
Analysis of the sla2-432 allele in the original strain used for the Rcb screen also revealed a role in cell viability for the yeast AP180 homologs, Yap1801p and Yap1802p. Deletion analyses have not thus far provided any insight into a function for these genes (![]()
![]()
CBM triple-
[pENT1]) upon loss of wild-type ENT1 is rescued by reintroducing either Yap1801p or Yap1802p (Fig 2A, rows 7 and 8). This provides the first evidence that these proteins perform an important function in yeast, which may be in supporting the roles of Ent1p and Ent2p as cargo selectors and/or clathrin assembly factors. In addition, it is possible that Yap1801p and Yap1802p may recognize uncharacterized endocytic signals on certain receptor proteins. These four potential clathrin-binding adaptor proteins share similarities, but perhaps Ent1p and Ent2p are more promiscuous and, in yap1801
yap1802
cells, can also select the cargo normally recognized by the yeast AP180s.
Sla2p as a regulator of actin and endocytosis:
The data available indicate that Sla2p may regulate both endocytosis and actin cytoskeletal dynamics. The actin cytoskeleton of sla2
cells is depolarized and found in larger, aggregate-like patches rather than in the smaller, finer actin patches seen in wild-type cells (![]()
![]()
![]()
CBM triple-
[pENT1]), F-actin patches are disrupted to the extent that most cells have only one large cortical actin patch (Fig 5C). Sla2p exhibits interactions with several actin-binding and -regulatory proteins, and here we demonstrate interactions with clathrin adaptors as well. We propose that the loss of adaptors at sites of endocytosis, in combination with mutant sla2-432, leads to a more severe defect in actin because either communication between Sla2p and adaptors is compromised or the malfunctioning Sla2 protein may reduce the spatial and temporal coordination necessary for proper coated pit formation. The recruitment or regulation of other critical adaptor-binding components such as Pan1p or Ede1p may also be compromised. Whether endocytic cues are capable of affecting actin organization to such a degree is unclear, but our results indicate that the loss of clathrin adaptors does have a strong effect on normal regulation of F-actin in cortical patches.
Remaining questions and future considerations:
It remains to be discovered how Sla2p is regulated, how the clathrin adaptors coordinate with Sla2p or with other actin regulators, and the order in which these factors recognize and respond to cues from endocytic sites on the plasma membrane. Sla2p also interacts with the regulatory kinase Ark1p, as well as Scd5p, a protein whose function is unknown; these interactions may also be important for regulation of Sla2p (![]()
![]()
| FOOTNOTES |
|---|
1 Present address: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank David Drubin, Susan Michaelis, Yidi Sun, and Wendland lab members for critical reading of the manuscript and helpful discussions. We also thank David Drubin, Sandra Lemmon, Susan Michaelis, Greg Payne, Robert Piper, and Trina Schroer for gifts of reagants, plasmids, and/or strains. This study was funded by a Burroughs Wellcome Fund New Investigator in the Pharmacological Sciences Award and National Institutes of Health GM-60979. J. Baggett was also funded by a National Science Foundation predoctoral fellowship.
Manuscript received May 1, 2003; Accepted for publication July 7, 2003.
| LITERATURE CITED |
|---|
AGUILAR, R. C., H. A. WATSON, and B. WENDLAND, 2003 The yeast epsin Ent1 is recruited to membranes through multiple independent interactions. J. Biol. Chem. 278:10737-10743.
AYSCOUGH, K. R., J. J. EBY, T. LILA, H. DEWAR, and K. G. KOZMINSKI et al., 1999 Sla1p is a functionally modular component of the yeast cortical actin cytoskeleton required for correct localization of both Rho1p-GTPase and Sla2p, a protein with talin homology. Mol. Biol. Cell 10:1061-1075.
BAGGETT, J. J. and B. WENDLAND, 2001 Clathrin function in yeast endocytosis. Traffic 2:297-302.[Medline]

, wild type (SEY6210); , ent1
, ent1
, ent1
, sla2-432 ent2
, sla2-432 ent2
